Novartis AG
SIX:NOVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVN
|
CH |
|
H
|
Hancock Whitney Corp
F:HH1
|
US |
|
Weyerhaeuser Co
NYSE:WY
|
US |
|
Trustmark Corp
NASDAQ:TRMK
|
US |
|
Rockwell Automation Inc
NYSE:ROK
|
US |
|
D
|
Discovery Ltd
JSE:DSY
|
ZA |
|
N
|
Nokia Oyj
PSE:NOKIA
|
FI |
|
N
|
Nucor Corp
DUS:NUO
|
US |
|
J
|
JD.com Inc
DUS:013C
|
CN |
|
A
|
AMN Healthcare Services Inc
F:HCQ
|
US |
|
Petroleo Brasileiro SA Petrobras
LSE:0KHP
|
BR |
|
B
|
Borgwarner Inc
F:BGW
|
US |
|
D
|
De' Longhi SpA
SWB:DLN
|
IT |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
Amalgamated Financial Corp
NASDAQ:AMAL
|
US |
|
Rolls-Royce Holdings PLC
OTC:RYCEF
|
UK |
|
G
|
Goldman Sachs Group Inc
F:GOS
|
US |
|
C
|
Cadence Design Systems Inc
XETRA:CDS
|
US |
|
I
|
Intesa Sanpaolo SpA
SWB:IES
|
IT |
|
Mirait One Corp
OTC:MRHLF
|
JP |
Bankruptcy Probability
Novartis AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novartis AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Novartis AG
SIX:NOVN
|
220.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
284.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novartis AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novartis AG has total debt of 39.2B USD. This includes both short-term (0 USD) and long-term (39.2B USD) debt.
You can find a full breakdown on its Balance Sheet.